Pass HI - Search Results

1

Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.

Shaw GL, Gazdar AF, Phelps R, Linnoila RI, Ihde DC, Johnson BE, Oie HK, Pass HI, Steinberg SM, Ghosh BC, et al. Shaw GL, et al. Among authors: pass hi. Cancer Res. 1993 Nov 1;53(21):5181-7. Cancer Res. 1993. PMID: 8221655 Clinical Trial.

2

Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma.

Temeck BK, Liebmann JE, Theodossiou C, Steinberg SM, Cook JA, Metz DC, Shawker TH, Allegra CJ, Russo A, Pass HI. Temeck BK, et al. Among authors: pass hi. Cancer. 1996 Jun 15;77(12):2432-9. doi: 10.1002/(SICI)1097-0142(19960615)77:12<2432::AID-CNCR3>3.0.CO;2-O. Cancer. 1996. PMID: 8640689 Clinical Trial.

3

Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.

Shaw GL, Gazdar AF, Phelps R, Steinberg SM, Linnoila RI, Johnson BE, Oie HK, Russell EK, Ghosh BC, Pass HI, Minna JD, Mulshine JL, Ihde DC. Shaw GL, et al. Among authors: pass hi. J Cell Biochem Suppl. 1996;24:173-85. doi: 10.1002/jcb.240630513. J Cell Biochem Suppl. 1996. PMID: 8806100 Clinical Trial.

4

Randomized trial of neoadjuvant therapy for lung cancer: interim analysis.

Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J, Minna J. Pass HI, et al. Ann Thorac Surg. 1992 Jun;53(6):992-8. doi: 10.1016/0003-4975(92)90373-c. Ann Thorac Surg. 1992. PMID: 1317697 Clinical Trial.

5

Computerized tomographic prediction of extraluminal spread and prognostic implications of lesion width in esophageal carcinoma.

Lefor AT, Merino MM, Steinberg SM, Dwyer A, Roth JA, Flanagan M, Pass HI. Lefor AT, et al. Among authors: pass hi. Cancer. 1988 Oct 1;62(7):1287-92. doi: 10.1002/1097-0142(19881001)62:7<1287::aid-cncr2820620707>3.0.co;2-5. Cancer. 1988. PMID: 3416270

6

Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.

Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, Minna JD. Sekido Y, et al. Among authors: pass hi. Cancer Res. 1995 Mar 15;55(6):1227-31. Cancer Res. 1995. PMID: 7882313

7

Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.

Pass HI, Mew DJ, Carbone M, Matthews WA, Donington JS, Baserga R, Walker CL, Resnicoff M, Steinberg SM. Pass HI, et al. Cancer Res. 1996 Sep 1;56(17):4044-8. Cancer Res. 1996. PMID: 8752177

8

Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma.

Alexander HR, Grem JL, Hamilton JM, Pass HI, Hong M, Fraker DL, Steinberg SM, McAtee N, Allegra BC, Johnston PG. Alexander HR, et al. Among authors: pass hi. Cancer J Sci Am. 1995 May-Jun;1(1):49-54. Cancer J Sci Am. 1995. PMID: 9166454 Clinical Trial.

9

Debrisoquine metabolism and lung cancer risk.

Shaw GL, Falk RT, Deslauriers J, Frame JN, Nesbitt JC, Pass HI, Issaq HJ, Hoover RN, Tucker MA. Shaw GL, et al. Among authors: pass hi. Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb;4(1):41-8. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7894323

10

In vitro photodynamic therapy of human lung cancer: investigation of dose-rate effects.

Matthews W, Cook J, Mitchell JB, Perry RR, Evans S, Pass HI. Matthews W, et al. Among authors: pass hi. Cancer Res. 1989 Apr 1;49(7):1718-21. Cancer Res. 1989. PMID: 2522346

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

478 results

Search Page